Clean Science IPO

Clean Science and Technology Ltd.

₹14,080 /16 sharesMinimum Investment

Clean Science IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
7 Jul ‘21 - 9 Jul ‘21₹14,08016₹880 - ₹900
Issue SizeIPO Doc
1546.62Cr
RHP PDF

Subscription Status As on 09 Jul '21, 4:55 PM

  • Retail Individual Investor
    8.98x
  • Non-Institutional Investor
    206.43x
  • Qualified Institutional Buyers
    156.37x

About Clean Science

Clean Science and Technology Limited focuses entirely on developing newer technologies using in-house catalytic processes, which are eco-friendly and cost-efficient. It manufactures functionally critical specialty chemicals like performance chemicals, pharmaceutical intermediates and FMCG chemicals. It is one of the largest manufacturers of certain specialty chemicals in terms of manufacturing capabilities. Its customers include manufacturers and distributors in India as well as other regulated international markets including China, Europe, the United States of America, Taiwan, Korea, and Japan.;
Parent Organisation
Clean Science and Technology Ltd.
Founded
2003
Managing Director
Ashok Ramnarayan
Clean Science and technology IPO review - Business, financials, IPO details | Upcoming IPO 2021

Strengths & Risks

  • Among the leading companies in India to have commercialized use of environment-friendly processes to manufacture certain specialty chemicals, at global capacities.
  • A low-risk business model since it is one of the largest manufacturers of certain specialty chemicals that have applications across industries.
  • Strong and long-standing relationships with its key customers.
  • Automated manufacturing facilities with proven design and commercialization capabilities and a strong focus on EHS (Environment, Health, and Safety).
  • It has delivered consistent growth over the last three financial years both in terms of financial and operational metrics.
  • High dependency on constantly designing catalytic processes for cost-efficiencies and R&D improvements.
  • The processes are not patented and the company’s intellectual property might not be adequately protected.
  • A significant portion of the company’s revenues is generated from key customers.
  • Disruption of its manufacturing operations for any reason.
  • Absence of long-term contracts with customers and suppliers.
  • Pending legal proceedings against the company and its directors.
  • Losses suffered by its Group Companies.
  • The majority of revenue is generated from the sale of MEHQ leading to dependence on its demand.
  • A capital-intensive business .
  • Competitive market.
  • Dependency on sales in international markets making exchange rate fluctuation a risk factor.
  • It operates in a hazardous industry and manufactures, uses, and stores certain hazardous substances.
  • The continuing impact of the COVID-19 pandemic.
  • Being a raw material provider, the demand for its chemicals relies on the demand for the end-products of its customers.

Financials

*All values are in Rs. Cr
No Graph Data To Display

Application details

Apply asPrice bandApply upto
For Clean Science IPO, eligible investors can apply as
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ

ABOUT GROWW